Literature DB >> 7678717

Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis.

M Schulze1, C J Pruchno, M Burns, P J Baker, R J Johnson, W G Couser.   

Abstract

In antibody-mediated glomerular disease, deposits of C3 (C3b) are common and are degraded by factor I to C3c and C3d. However, the kinetics of C3b degradation in glomerulonephritis have not been defined. To do this, we studied three models of complement-dependent glomerulonephritis with established C3 deposits (passive Heymann nephritis, cationized immunoglobulin G membranous nephropathy, and concanavalin A-anticoncanavalin A glomerulonephritis). C3b deposition was halted by administration of cobra venom factor, and the disappearance of C3c and C3d from glomeruli was measured with specific antibodies and quantitative fluorescence densitometry. Results showed that C3c deposits were reduced by over 85% within 24 hours in all three models. C3c clearance was unaffected by site or mechanism of deposit formation. C3d deposits persisted despite lack of ongoing complement activation. In passive Heymann nephritis when disease activity was monitored by urinary C5b-9 excretion, C3c was cleared in parallel with return of urine C5b-9 excretion to normal values. We conclude that glomerular deposits of C3c are cleared within 24 hours of cessation of complement activation. Positive staining for C3 utilizing antibody specific for the C3c portion documents recent complement activation usually reflecting new immune deposit formation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678717      PMCID: PMC1886837     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

Review 2.  The beta-Cys-gamma-Glu thiolester bond in human C3, C4, and alpha 2-macroglobulin.

Authors:  B F Tack
Journal:  Springer Semin Immunopathol       Date:  1983

3.  Idiopathic membranous nephropathy.

Authors:  A M Pierides; P Malasit; A R Morley; R Willkinson; P R Uldall; D N Kerr
Journal:  Q J Med       Date:  1977-04

4.  Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases: loss of C3b receptor antigen in focal hyalinosis and in proliferative nephritis of systemic lupus erythematosus.

Authors:  M D Kazatchkine; D T Fearon; M D Appay; C Mandet; J Bariety
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

5.  Complement activation by heat-killed human kidney cells: formation, activity, and stabilization of cell-bound C3 convertases.

Authors:  P J Baker; S Adler; Y Yang; W G Couser
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

6.  Demonstration of C3d deposits in membranous nephropathy.

Authors:  T Doi; K Kanatsu; H Nagai; F Suehiro; T Kuwahara; Y Hamashima
Journal:  Nephron       Date:  1984       Impact factor: 2.847

7.  Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals.

Authors:  D J Salant; C Darby; W G Couser
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

8.  Differential characteristics of immune-bound antibodies in diffuse proliferative and membranous forms of lupus glomerulonephritis.

Authors:  J L Roberts; R J Wyatt; M M Schwartz; E J Lewis
Journal:  Clin Immunol Immunopathol       Date:  1983-11

9.  Pathologic differentiation between lupus and nonlupus membranous glomerulopathy.

Authors:  J C Jennette; S S Iskandar; F G Dalldorf
Journal:  Kidney Int       Date:  1983-09       Impact factor: 10.612

10.  Tissue culture of normal rat glomeruli. Isolation and morphological characterization of two homogeneous cell lines.

Authors:  J B Foidart; C A Dechenne; P Mahieu; C E Creutz; J de Mey
Journal:  Invest Cell Pathol       Date:  1979 Jan-Mar
View more
  19 in total

Review 1.  Experimental membranous nephropathy redux.

Authors:  Andrey V Cybulsky; Richard J Quigg; David J Salant
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

2.  Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice.

Authors:  Fadi Fakhouri; Elena Goicoechea de Jorge; Frédérique Brune; Philippe Azam; H Terence Cook; Matthew C Pickering
Journal:  Kidney Int       Date:  2010-05-05       Impact factor: 10.612

3.  Utility of immunohistochemistry with C3d in C3 glomerulopathy.

Authors:  Jan U Becker; Marian C Clahsen-van Groningen; Malou L H Snijders; Bojou J van de Wall-Neecke; Dennis A Hesselink
Journal:  Mod Pathol       Date:  2019-09-02       Impact factor: 7.842

4.  Complement factor I promotes progression of cutaneous squamous cell carcinoma.

Authors:  Pilvi Riihilä; Liisa Nissinen; Mehdi Farshchian; Atte Kivisaari; Risto Ala-Aho; Markku Kallajoki; Reidar Grénman; Seppo Meri; Sirkku Peltonen; Juha Peltonen; Veli-Matti Kähäri
Journal:  J Invest Dermatol       Date:  2014-09-03       Impact factor: 8.551

5.  The predictive value of peritubular capillaries C3d deposition in IgA glomerulonephritis.

Authors:  Mihaela Gherghiceanu; M Penescu; E Mandache
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

6.  Detection of complement activation using monoclonal antibodies against C3d.

Authors:  Joshua M Thurman; Liudmila Kulik; Heather Orth; Maria Wong; Brandon Renner; Siranush A Sargsyan; Lynne M Mitchell; Dennis E Hourcade; Jonathan P Hannan; James M Kovacs; Beth Coughlin; Alex S Woodell; Matthew C Pickering; Bärbel Rohrer; V Michael Holers
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

7.  Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy.

Authors:  Piero Ruggenenti; Paolo Cravedi; Maria Chiara Sghirlanzoni; Elena Gagliardini; Sara Conti; Flavio Gaspari; Gianfranco Marchetti; Mauro Abbate; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2008-08-06       Impact factor: 8.237

8.  Differential deposition of C4d and MBL in glomeruli of patients with ANCA-negative pauci-immune crescentic glomerulonephritis.

Authors:  Guang-qun Xing; Min Chen; Gang Liu; Xin Zheng; Jie E; Ming-hui Zhao
Journal:  J Clin Immunol       Date:  2009-11-07       Impact factor: 8.317

9.  C3, C4, factor B and HLA-DR alpha mRNA expression in renal biopsy specimens from patients with IgA nephropathy.

Authors:  R Oren; J Laufer; I Goldberg; J Kopolovic; R Waldherr; J H Passwell
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

10.  Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.

Authors:  Pilvi M Riihilä; Liisa M Nissinen; Risto Ala-Aho; Markku Kallajoki; Reidar Grénman; Seppo Meri; Sirkku Peltonen; Juha Peltonen; Veli-Matti Kähäri
Journal:  J Invest Dermatol       Date:  2013-08-12       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.